The Current Ratio as of November 2024 (TTM) for Novartis AG (NVSEF) is 1.11

According to Novartis AG’s latest financial reports and current stock price. The company's current Current Ratio is 1.11. This represents a change of 8.43% compared to the average of 1.02 of the last 4 quarters.

Novartis AG (NVSEF) Historical Current Ratio (quarterly & annually)

How has NVSEF Current Ratio performed in the past?

The mean historical Current Ratio of Novartis AG over the last ten years is 1.18. The current 1.11 Current Ratio has changed 9.33% with respect to the historical average. Over the past ten years (40 quarters), NVSEF's Current Ratio was at its highest in in the December 2021 quarter at 1.51. The Current Ratio was at its lowest in in the March 2021 quarter at 0.74.

Novartis AG (NVSEF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Novartis AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novartis AG (NVSEF) Average Current Ratio

How has NVSEF Current Ratio performed in the past?

The current Current Ratio of Novartis AG (NVSEF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Novartis AG (NVSEF) Current Ratio vs. Peers

How is NVSEF’s Current Ratio compared to its peers?

Novartis AG’s Current Ratio is less than Roche Holding AG (1.26), greater than AstraZeneca PLC (0.89), less than Roche Holding AG (1.26), greater than Sanofi (1.00), less than Bristol-Myers Squibb Company PFD CONV 2 (1.24), less than Astellas Pharma Inc. (0), greater than Roche Holding AG (0.90), less than Scilex Holding Company (1.26), greater than Novartis AG (0.20), less than AstraZeneca PLC (1.11), greater than GSK plc (0.89), greater than Bayer Aktiengesellschaft (0.81), less than Organon & Co. (1.27), less than Horizon Therapeutics Public Limited Company (1.70), less than null (4.27),

Build a custom stock screener for Novartis AG (NVSEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novartis AG (NVSEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.